Related Experiment Video
Updated: Oct 9, 2025

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Broad-spectrum antimicrobial consumption trends and correlation with bacterial infections and antimicrobial
Renata A P Sakata1, Rodrigo Cayô da Silva2, Ana C Gales3
1Universidade Federal de São Paulo (UNIFESP), Laboratório Especial de Microbiologia Clínica (LEMC), Division of Infectious Diseases, Department of Internal Medicine, Escola Paulista de Medicina (EPM), São Paulo, SP, Brazil.
Objectives:
Consumption trends of four broad-spectrum antimicrobials and their correlation with antimicrobial resistance in Gram-negative bacilli (GNB) from 2013-2017 within intensive care units (ICUs) were explored.
Methods:
Consumption of meropenem (MEM), polymyxin B (PMB), piperacillin/tazobactam (TZP) and cefepime (FEP) in defined daily doses per 1000 patient-days (DDD/1000PD) was measured. Infection-related GNB isolates were grouped according to specific resistance profiles. Time series of antimicrobial consumption and their parametric correlation with each grouped resistant GNB were explored.
Results:
A total of 1423 GNB were evaluated. A significant linear decline in consumption was observed for MEM [slope -3.88, 95% confidence interval (CI) -4.96 to -2.81; P < 0.0001] and PMB (slope -3.51, 95% CI -5.528 to -1.495; P = 0.0009). A significant decline in MEM-non-susceptible Acinetobacter spp. (R2 = 0.476; P = 0.006) and an increase in FEP-non-susceptible Escherichia coli (R2 = 0.124; P = 0.006) was observed. A significant correlation between MEM consumption and MEM-non-susceptible Acinetobacter spp. (r = 0.43; P = 0.001) was observed. MEM consumption and MEM-non-susceptible Acinetobacter spp. showed a positive correlation.
Conclusion:
Reduction in the consumption of broad-spectrum antimicrobials may alter the frequency of infection-related isolates and their antimicrobial resistance profiles.
Insights
Reducing broad-spectrum antimicrobial use, including meropenem and polymyxin B, in ICUs correlated with changes in Gram-negative bacilli resistance. Decreased meropenem consumption was linked to reduced resistance in Acinetobacter spp.
Area of Science:
- Infectious Diseases
- Clinical Pharmacy
- Microbiology
Background:
- Antimicrobial resistance (AMR) is a major global health threat, particularly in intensive care units (ICUs).
- Understanding the relationship between antimicrobial consumption patterns and the emergence of resistant pathogens is crucial for effective stewardship.
Purpose of the Study:
- To investigate the consumption trends of four broad-spectrum antimicrobials: meropenem (MEM), polymyxin B (PMB), piperacillin/tazobactam (TZP), and cefepime (FEP).
- To explore the correlation between the consumption of these antimicrobials and antimicrobial resistance in Gram-negative bacilli (GNB) isolates from ICUs between 2013 and 2017.
Main Methods:
- Consumption of MEM, PMB, TZP, and FEP was quantified in defined daily doses per 1000 patient-days (DDD/1000PD).
- Infection-related GNB isolates were categorized by specific resistance profiles.
- Time series analysis was employed to assess the parametric correlation between antimicrobial consumption and resistant GNB isolates.
Main Results:
- A significant linear decline in the consumption of meropenem (MEM) and polymyxin B (PMB) was observed.
- A significant decrease in MEM-non-susceptible Acinetobacter spp. was noted, correlating positively with MEM consumption.
- An increase in FEP-non-susceptible Escherichia coli was observed, with a significant correlation to FEP consumption.
Conclusions:
- Reducing the consumption of broad-spectrum antimicrobials can influence the prevalence of infection-related isolates.
- The findings highlight a complex interplay between antimicrobial prescribing practices and the development of antimicrobial resistance in GNB within the ICU setting.
More Related Videos
06:54Author Spotlight: Understanding and Detecting Environmental Antimicrobial Resistance by Combining Culture-Based Techniques and Genomics
Published on: July 19, 2024
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Related Concept Videos
Antibiotic Selection
Development of Antibiotic Resistance
Antimicrobial Effectiveness
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...